Cargando…
LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506447/ http://dx.doi.org/10.1016/j.annonc.2020.08.2318 |
| _version_ | 1783585020379660288 |
|---|---|
| author | Marra, A. Generali, D.G. Zagami, P. Gandini, S. Cervoni, V. Venturini, S. Morganti, S. Passerini, R. Orecchia, R. Curigliano, G. |
| author_facet | Marra, A. Generali, D.G. Zagami, P. Gandini, S. Cervoni, V. Venturini, S. Morganti, S. Passerini, R. Orecchia, R. Curigliano, G. |
| author_sort | Marra, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506447 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75064472020-09-23 LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study Marra, A. Generali, D.G. Zagami, P. Gandini, S. Cervoni, V. Venturini, S. Morganti, S. Passerini, R. Orecchia, R. Curigliano, G. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506447/ http://dx.doi.org/10.1016/j.annonc.2020.08.2318 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Marra, A. Generali, D.G. Zagami, P. Gandini, S. Cervoni, V. Venturini, S. Morganti, S. Passerini, R. Orecchia, R. Curigliano, G. LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study |
| title | LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study |
| title_full | LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study |
| title_fullStr | LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study |
| title_full_unstemmed | LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study |
| title_short | LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study |
| title_sort | lba77 anti-sars-cov-2 antibody response in patients with cancer and oncology healthcare workers: a multicenter, prospective study |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506447/ http://dx.doi.org/10.1016/j.annonc.2020.08.2318 |
| work_keys_str_mv | AT marraa lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT generalidg lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT zagamip lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT gandinis lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT cervoniv lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT venturinis lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT morgantis lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT passerinir lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT orecchiar lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy AT curiglianog lba77antisarscov2antibodyresponseinpatientswithcancerandoncologyhealthcareworkersamulticenterprospectivestudy |